- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Solid or Liquid Cancer
Total 3789 results
-
University Hospital, BordeauxNovartis; National Cancer Institute, France; Fondation ARCRecruitingRefractory or Recurrent Solid TumorFrance
-
Shanghai Pharmaceuticals Holding Co., LtdRecruiting
-
Sidney Kimmel Comprehensive Cancer Center at Johns...RecruitingRefractory and/or Relapsed Metastatic Solid TumorsUnited States
-
MedImmune LLCCompletedRecurrent or Metastatic Solid TumorsUnited States, Australia
-
M.D. Anderson Cancer CenterCompletedSolid Tumor | Advanced CancerUnited States
-
AstraZenecaTerminatedCancer | Advanced Solid MalignanciesUnited States, Italy, United Kingdom, France, Germany, Spain, Netherlands
-
Bien-Willner Physicians Group PANo One Left Alone; Carolina Blood and Cancer Care AssociatesNot yet recruitingAdvanced Cancer | Myeloid Malignancy | Solid Tumor, AdultUnited States
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Cancer SurvivorUnited States
-
Tachyon Therapeutics, Inc.RecruitingSolid Tumor | Metastatic Solid Tumor | Advanced CancerUnited States
-
National Cancer Institute (NCI)RecruitingMetastatic Solid Tumors | Treatment-Refractory CancersUnited States
-
Astellas Pharma Global Development, Inc.Seagen Inc.CompletedMetastatic Urothelial Cancer and Other Malignant Solid TumorsUnited States, Canada
-
Incyte CorporationNovartis PharmaceuticalsCompletedSolid Tumor | Metastatic Cancer | Advanced CancerUnited States
-
Merck Sharp & Dohme LLCRecruitingAdvanced or Metastatic Solid TumorsCanada, Switzerland, United States
-
Merck Sharp & Dohme LLCActive, not recruitingAdvanced or Metastatic Solid TumorsChile, Hungary, Korea, Republic of, South Africa, Spain, Japan
-
Duke UniversityCompletedA Diagnosis of Any Hematologic or Solid MalignancyUnited States
-
PfizerCompletedBreast Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | NSCLC | Prostate Cancer | Advanced Solid Tumors | Solid TumorsUnited States, Australia
-
Allarity TherapeuticsCompletedPhase 1: Advanced or Refractory Solid Tumours | Phase 2 Part: Metastatic Breast Cancer, Prostate Cancer and Skin CancerDenmark
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingLocally Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | ROS1 Gene Rearrangement | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IV Lung Non-Small Cell Cancer AJCC v7 | ALK PositiveUnited States
-
Keystone Nano, IncNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedCarcinoma | Cancer | Solid Tumors | TumorUnited States
-
Redx Pharma PlcActive, not recruitingCancer | Solid TumorUnited Kingdom
-
Deciphera Pharmaceuticals LLCRecruitingNon-Small Cell Lung Cancer | Advanced Solid Tumor | Metastatic Solid TumorUnited States
-
Washington University School of MedicineMerck Sharp & Dohme LLC; The Foundation for Barnes-Jewish Hospital; Verastem,...CompletedPancreatic Cancer | Advanced Solid Tumors | Solid TumorsUnited States
-
PfizerCompletedA Safety And Pharmacokinetic Study With CVX-045 In Patients With Advanced Solid Tumors (CVX-045-101)Neoplasms | Carcinoma | Cancer | Advanced Solid Tumors | MalignancyUnited States
-
Relay Therapeutics, Inc.RecruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Solid Tumor, Adult | HER2-negative Breast Cancer | Unresectable Solid Tumor | PIK3CA MutationUnited States, Spain, France, Italy
-
University Health Network, TorontoBayer; AstraZeneca; Amgen; AnHeart Therapeutics Inc.; Applied Health Research Centre and other collaboratorsRecruitingCancer | Malignancies Multiple | Malignant Solid Tumor | Cancer, Therapy-Related | Molecular Sequence Variation | Genetic Alteration | Gene Fusion | Receptor Tyrosine Kinase Gene Mutation | RTK Family Gene Mutation | Ras (Kras or Nras) Gene MutationCanada
-
Washington University School of MedicineCompletedSolid Tumor | Solid MalignancyUnited States
-
Genentech, Inc.RecruitingMelanoma | Cervical Cancer | HCC | Gastric Cancer | Esophageal Cancer | NSCLC | Urothelial Carcinoma | HNSCC | Locally Advanced or Metastatic Solid Tumors | TNBC | Clear Cell RCCKorea, Republic of, Netherlands, Spain, United States, Australia, Canada, Belgium
-
EpicentRx, Inc.TerminatedMetastatic Cancer | Advanced Cancer | Malignant Solid TumorUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownMSI-H or dMMR Advanced Solid TumorsChina
-
Curegenix Inc.Merck Sharp & Dohme LLCRecruitingSolid Tumors | GI CancerUnited States, Taiwan
-
Kyowa Kirin Co., Ltd.RecruitingAdvanced or Metastatic Solid TumorsJapan
-
Novartis PharmaceuticalsCompletedMetastatic or Locally Advanced Solid TumorsNetherlands, Spain, Germany, Switzerland, Belgium
-
OncoResponse, Inc.RecruitingCancer | Metastatic Cancer | Advanced Solid Tumor | Platinum-resistant Ovarian Cancer | Malignant Neoplasm | Tumor, Solid | Cutaneous Squamous Cell CarcinomaUnited States
-
Advanced Integrative Medical Science InstituteRecruitingNeoplasms | Advanced Solid Tumor | Advanced Cancer | Oncology | Neoplasm MalignantUnited States
-
Washington University School of MedicineMolecular Templates, Inc.WithdrawnHER2-positive Solid Tumor | HER-2 Positive Cancer
-
PfizerCompletedNeoplasms | Carcinoma | Cancer | Advanced Solid Tumors | MalignancyUnited States
-
ImmunityBio, Inc.Active, not recruitingSolid Tumor | Metastatic Cancer | Locally Advanced Solid TumorUnited States
-
National Cancer Institute (NCI)Active, not recruitingNeoplasms | Cancer | Solid TumorsUnited States
-
AbbVie (prior sponsor, Abbott)CompletedPrimary Peritoneal Cancer | Fallopian Tube | Solid Tumors (e.g. Breast, Ovarian, Prostate, or Pancreatic) and OvarianNetherlands
-
Hoffmann-La RocheCompletedLocally Advanced Solid Tumors | Metastatic Solid TumorsUnited States, Korea, Republic of
-
Taiho Oncology, Inc.TerminatedAdvanced Solid Tumors With HER2 Abnormalities | Advanced Solid Tumors With HER3 AbnormalitiesUnited States, Spain, France, United Kingdom
-
AbbVieNo longer availableHigh Grade Serous Ovarian Cancer | Solid Tumors With Documented BRCA, BARD, or PALB or Other Acceptable DNA Mutations or Anomalies That Are Scientifically Sound | Triple Negative Breast Cancer (TNBC) | Patients Requiring Veliparib Suspension Formulation
-
Relay Therapeutics, Inc.Active, not recruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Solid Tumor, Adult | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor | Unresectable Solid Tumor | PIK3CA MutationUnited States
-
Peking UniversityRecruitingConditions or Focus of Study: B7-H3 Positive Relapsed/Advanced Malignant Solid TumorChina
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLCActive, not recruitingSolid Tumors | Identified by NGS, PCR or IHCUnited States
-
Xuanzhu Biopharmaceutical Co., Ltd.RecruitingLocally Advanced or Metastatic Solid Tumors | Locally Advanced or Metastatic Non-small Cell Lung CancerChina
-
Memorial Sloan Kettering Cancer CenterRecruitingMetastatic Solid Tumor | Advanced CancerUnited States
-
AmMax Bio, Inc.CompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
M.D. Anderson Cancer CenterCompleted
-
AmgenCompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States